気道ステントの世界市場：2025年から2030年までの予測

気道ステント市場は、CAGR 5.16％で2025年の1億4,101万7,000米ドルから2030年には1億8,133万1,000米ドルに成長すると予測されています。

気道ステント市場は、呼吸器系慢性疾患の有病率の上昇と低侵襲手技の採用増加により、2025～2030年にかけて大きく成長すると予測されています。気道ステントは、機械的デブリードマン、レーザー切除、光線力学的療法、気管支内ブラキセラピーなどの手技を通じて、中枢気道の良性と悪性病変を管理するために使用され、肺がん、結核、慢性閉塞性肺疾患（COPD）などの疾患の治療に不可欠です。市場は、生分解性ステントや薬剤溶出性ステントの進歩、汚染レベルの上昇、タバコの喫煙率の高さによって推進されています。北米が市場をリードする一方、アジア太平洋は高い成長の可能性を示しています。課題としては、ステント留置に伴う合併症が挙げられます。

市場促進要因

呼吸器疾患の有病率の上昇

肺がん、結核、COPDなどの慢性呼吸器疾患の発生率の増加は、気道ステント市場の主要促進要因です。世界の汚染レベルの上昇とタバコ喫煙率の高止まりが、これらの疾患の負担増に寄与しています。気道ステントは、閉塞性病変を持つ患者の気道開存性を維持し、治療と緩和ケアの両方をサポートするために不可欠です。これらの病態を管理するための効果的な介入に対するニーズの高まりが、先進的ステント技術に対する需要を促進しています。

低侵襲治療への嗜好

従来型手術に比べて回復時間が短縮され、合併症リスクも低い低侵襲手技への嗜好の高まりが、気道ステントの採用を後押ししています。内視鏡的ステント留置のような治療技術は、気道閉塞の正確な治療を可能にし、患者の転帰を改善します。この動向は特に病院や外来手術センターで顕著であり、低侵襲的アプローチが標準治療プロトコルに組み込まれるようになってきているため、市場の成長をさらに促進しています。

ステント技術の進歩

生分解性ステントと薬剤溶出性気道ステントの技術革新が市場の成長を促進しています。生分解性ステントは除去処置の必要性をなくし、長期的な合併症を減少させる一方、薬剤溶出性ステントは再狭窄や炎症を予防する標的治療を記載しています。これらの進歩は患者の安全性と治療効果を向上させ、臨床現場での採用を促進し、市場の拡大を支えています。

市場抑制要因

気道ステント市場は、ステント留置に伴う移動、感染、肉芽組織形成などの合併症による課題に直面しており、これが採用を阻害し、ヘルスケアコストを増加させる可能性があります。先進的ステントの高価格や、内視鏡手技を行うための熟練した専門家の必要性も、特にヘルスケアインフラが限られている発展途上地域では障壁となります。ステントの設計やトレーニングプログラムの改善を通じてこれらの課題に対処することが、市場の持続的成長には不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 市場スナップショット

• 市場概要
• 市場の定義
• 調査範囲
• 市場セグメンテーション

第3章 ビジネス情勢

• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析
• 産業バリューチェーン分析
• 施策と規制
• 戦略的提言

第4章 技術展望

第5章 気道ステントの世界市場：材料タイプ別

• イントロダクション
• 金属
• シリコーン
• ハイブリッド

第6章 気道ステントの世界市場：エンドユーザー別

• イントロダクション
• 病院とクリニック
• 外来手術センター

第7章 気道ステントの世界市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • その他
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • インドネシア
  • タイ
  • その他

第8章 競合環境と分析

• 主要企業と戦略分析
• 市場シェア分析
• 合併、買収、合意とコラボレーション
• 競合ダッシュボード

第9章 企業プロファイル

• Boston Scientific Corporation
• Novatech SA
• Cook Medical
• MICRO-TECH Europe GmbH
• Medtronic
• Cook Medical
• MICRO-TECH（Nanjing）Co., Ltd.
• Merit Medical Systems

第10章 調査手法

The global airway stent market is expected to grow from USD 141.017 million in 2025 to USD 181.331 million in 2030, at a CAGR of 5.16%.

The global airway stent market is projected to experience significant growth from 2025 to 2030, driven by the rising prevalence of respiratory chronic disorders and the increasing adoption of minimally invasive procedures. Airway stents, used to manage benign and malignant lesions in the central airway through techniques like mechanical debridement, laser resection, photodynamic therapy, and endobronchial brachytherapy, are critical for treating conditions such as lung cancer, tuberculosis, and chronic obstructive pulmonary disease (COPD). The market is propelled by advancements in biodegradable and drug-eluting stents, rising pollution levels, and high tobacco smoking rates. North America leads the market, while Asia-Pacific shows strong growth potential. Challenges include complications associated with stent implantation.

Market Drivers

Rising Prevalence of Respiratory Disorders

The increasing incidence of chronic respiratory conditions, including lung cancer, tuberculosis, and COPD, is a primary driver of the airway stent market. Rising pollution levels and the persistent high prevalence of tobacco smoking globally contribute to the growing burden of these diseases. Airway stents are essential for maintaining airway patency in patients with obstructive lesions, supporting both therapeutic and palliative care. The escalating need for effective interventions to manage these conditions is driving demand for advanced stent technologies.

Preference for Minimally Invasive Procedures

The growing preference for minimally invasive procedures, which offer reduced recovery times and lower complication risks compared to traditional surgeries, is boosting the adoption of airway stents. Techniques like endoscopic stent placement enable precise treatment of airway obstructions, improving patient outcomes. This trend is particularly prominent in hospitals and ambulatory surgical centers, where minimally invasive approaches are increasingly integrated into standard care protocols, further fueling market growth.

Advancements in Stent Technology

Innovations in biodegradable and drug-eluting airway stents are enhancing market growth. Biodegradable stents eliminate the need for removal procedures, reducing long-term complications, while drug-eluting stents deliver targeted therapies to prevent restenosis and inflammation. These advancements improve patient safety and treatment efficacy, driving adoption across clinical settings and supporting the market's expansion.

Market Restraints

The airway stent market faces challenges due to complications associated with stent implantation, such as migration, infection, or granulation tissue formation, which can deter adoption and increase healthcare costs. The high cost of advanced stents and the need for skilled professionals to perform endoscopic procedures also pose barriers, particularly in developing regions with limited healthcare infrastructure. Addressing these challenges through improved stent designs and training programs will be critical for sustained market growth.

Market Segmentation

By Material Type

The market is segmented into metal, silicone, and hybrid stents. Silicone stents dominate due to their flexibility and biocompatibility, making them suitable for long-term use in benign conditions. Metal stents are preferred for malignant obstructions due to their durability, while hybrid stents, combining metal and silicone properties, are gaining traction for their versatility in complex cases.

By End-User

The market is divided into hospitals and clinics, and ambulatory surgical centers. Hospitals and clinics hold the largest share, driven by their advanced infrastructure and high volume of respiratory procedures. Ambulatory surgical centers are a growing segment, supported by the increasing adoption of minimally invasive techniques in outpatient settings.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads due to its advanced healthcare systems, high prevalence of respiratory disorders, and early adoption of innovative stent technologies. Asia-Pacific is expected to grow rapidly, driven by increasing healthcare investments, rising pollution levels, and growing awareness of respiratory health in countries like China and India. Europe, South America, and the Middle East and Africa are emerging markets, supported by improving healthcare infrastructure.

The airway stent market is set for robust growth from 2025 to 2030, driven by the rising prevalence of respiratory disorders, preference for minimally invasive procedures, and advancements in biodegradable and drug-eluting stents. Despite challenges from implantation complications and high costs, the market's outlook is positive, particularly in North America and Asia-Pacific. Industry players must focus on innovative stent designs, cost-effective solutions, and clinician training to capitalize on the growing demand for airway stents in managing chronic respiratory conditions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Different segments covered under the global airway stent market report are as below:

By Material Type

• Metal
• Silicone
• Hybrid

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL AIRWAY STENT MARKET BY MATERIAL TYPE

• 5.1. Introduction
• 5.2. Metal
• 5.3. Silicone
• 5.4. Hybrid

6. GLOBAL AIRWAY STENT MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals and Clinics
• 6.3. Ambulatory Surgical Centers

7. GLOBAL AIRWAY STENT MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. United Kingdom
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East & Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Israel
  • 7.5.4. Others
• 7.6. Asia Pacific
  • 7.6.1. Japan
  • 7.6.2. China
  • 7.6.3. India
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Boston Scientific Corporation
• 9.2. Novatech SA
• 9.3. Cook Medical
• 9.4. MICRO-TECH Europe GmbH
• 9.5. Medtronic
• 9.6. Cook Medical
• 9.7. MICRO-TECH (Nanjing) Co., Ltd.
• 9.8. Merit Medical Systems

10. RESEARCH METHODOLOGY